Skip to main content
Premium Trial:

Request an Annual Quote

Dharmacon s RNAi Technical Reference & Application Guide, Applied Biosystems TaqMan, and SuperArray Bioscience s Oligo GEArray

Premium

Dharmacon is providing free copies of its RNAi Technical Reference & Application Guide.

The guide covers such topics as method comparison, experimental design, and protocols.

Information on receiving a copy of the guide can be found at http://design.dharmacon.com/genelist/rnaiguide/default.aspx?SID=326222166.


Applied Biosystems said this week that it has introduced for its TaqMan gene expression assays more than 350,000 new pre-designed probe and primer sets. These are in addition to the current 40,000 off-the-shelf assays available for the platform.

“The new assays were designed over all viable exon junctions of transcripts associated with human, mouse, and rat genes, which may be especially important for researchers wanting to distinguish between biologically relevant splice variants of genes,” Andrew Last, vice president and general manager of Applied Biosystems gene expression, core PCR, and DNA synthesis, said in a statement. “Additionally, researchers conducting RNAi experiments now have a highly efficient and accurate method to confirm levels of gene knock-out or knock-down, including access to specific transcript locations needed for detection.”


SuperArray Bioscience said this week that it has launched the first two arrays in its new line of pathway-specific Oligo GEArray focused DNA microarrays.

These arrays include gene content specific to human hematology and human cancer, said the company.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.